Significance of serum laminin P1 values in patients with transitional cell carcinoma of the bladder

Urology

Volumn 48, Issue 3, 1996, Pages 496-500

  Mungan, Uǧur ^a   Kirkali, Güldal ^a   Çelebi, Ilhan ^a   Kirkali, Ziya ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 0030249320     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00215-4     Document Type: Article

References (23)

1. Meuleman EJH, and Delaere KP: Diagnostic efficacy of the combination of urine cytology, urine analysis and history in the follow-up of bladder carcinoma. Br J Urol 62: 150-153, 1988.
2. Thrasher JB, and Crawford ED: Current management of invasive and metastatic transitional cell carcinoma of the bladder. J Urol 149: 957-972, 1993.
3. Abel PD: Prognostic indices in transitional cell carcinoma of the bladder. Br J Urol 62: 103-109, 1988.
4. Witjes JA, Kiemeney LALM, Oosterhof GON, and Debruyne FMJ: Prognostic factors in superficial bladder cancer. Eur Urol 21: 89-97, 1992.
5. Martinez-Hernandez A, and Amenta PS: The basement membrane in pathology. Lab Invest 48: 656-677, 1983.
6. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart J-M, and Martin GR: Laminin - a glycoprotein from basement membranes. J Biol Chem 254: 9933-9937, 1979.
7. Liotta LA: Tumor invasion and metastases: role of the basement membrane. Am J Pathol 117: 339-347, 1984.
8. Liotta LA, Rao CN, and Barsky SH: Tumor invasion and extracellular matrix. Lab Invest 49: 636-649, 1983.
9. Dubeau L, and Jones PA: Tumor invasion and ability to metastasize. Genitourin Cancer 1:3-15, 1988.
10. Smedsrod B, Paulsson M, Johansson S, and Smedsra B: Uptake and degradation in vivo and in vitro of laminin and nidogen by rat liver cells. Biochem J 261: 37-42, 1989.
11. AbouFarha KMM, Menheere PPCA, Nieman FHM, Arends JW, and Janknegt RA: Value of serum laminin P1 as a diagnostic and monitoring parameter in transitional cell carcinoma of the bladder. Urol Int 49: 130-136, 1992.
12. AbouFarha KMM, Menheere PPCA, Bruins JL, Kester ADM, and Janknegt R: The role of serum laminin P1 in the diagnosis of transitional cell carcinoma of the bladder. Eur Urol 21: 240-244, 1992.
13. Albrechtsen R, Nielsen M, Wewer U, Engvalle E, and Ruoslahti E: Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 41: 5076-5081, 1981.
14. Hashimoto H, and Sakashita S: Laminin - a basement membrane specific glycoprotein - in bladder carcinomas. Urol Int 41: 248-253, 1986.
15. Kropf J, Gressner AM, and Negwer A: Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases. Clin Chem 34: 2026-2030, 1988.
16. Larbre H, Loemba L, and Deltour G: Dosage du fragment P1 de la laminine par une technique radioimmunologique: applications en cancerologie [Assay of the laminin P1 using a radioimmunologic technique: applications in oncology]. Bull Cancer 76: 947-953, 1989.
17. Pietschmann P, Schernthaner G, Schnack CH, and Gaube S: Serum concentrations of laminin P1 in diabetics with advanced nephropathy. J Clin Pathol 41: 929-932, 1988.
18. Rochlitz C, Hasslacher C, Brocks DG, and Herrmann R: Serum concentration of laminin, and course of the disease in patients with various malignancies. J Clin Oncol 5: 1424-1429, 1987.
19. Conn IG, Crocker J, Wallace DMA, Hughes MA, and Hilton CJ: Basement membranes in urothelial carcinoma. Br J Urol 60: 536-542, 1987.
20. Iwata S, Isobe H, Fujime M, Kitagawa R, Horikoshi S, Funabiki K, and Koide H: Serum concentration of laminin in transitional cell carcinoma. Nippon Hinyokika Gakkai Zasshi 81: 518-523, 1990.
21. AbouFarha KMM, Janknegt RA, Kester ADM, and Arends JW: Value of immunohistochemical laminin staining in transitional cell carcinoma of human bladder. Urol Int 50: 133-140, 1993.
22. AbouFarha KMM, Menheere PPCA, Nieman FHM, Janknegt RA, and Arenas JW: Relation between basement membrane degradation and serum levels of laminin P1 in patients with transitional cell carcinoma of the bladder. Urol Int 50: 13-16, 1993.
23. AbouFarha KMM, Menheere PPCA, Nieman FHM, Janknegt RA, and Arends JW: Urine laminin P1 assesment discriminates between invasive and noninvasive urothelial cell carcinoma of the bladder. Urol Int 51: 204-208, 1993.